L01CD02 |
B |
Docetaxel (trihydrated) - 20mg/ml |
1780 |
208396/97 |
TAXOTERE |
20mg/ml |
1 x 0.5ml + 1.5ml |
Injectable concentrated solution+diluent |
Infusion |
Mersaco |
Sanofi Aventis Deutschland GmbH |
Germany |
6,574,078 L.L |
23.08 |
B |
Aventis Pharma SA |
France |
03/07/20 |
|
L01CD02 |
B |
Docetaxel (trihydrated) - 20mg/ml |
11068 |
81822/1 |
TAXOTERE |
20mg/ml |
1 x 0.5ml + 1.5ml |
Injectable concentrated solution+diluent |
Infusion |
Mersaco |
Sanofi Aventis Deutschland GmbH |
Germany |
6,574,078 L.L |
23.08 |
B |
Sanofi Mature IP |
France |
03/07/20 |
|
L01CD02 |
G |
Docetaxel - 20mg/2ml |
5867 |
218936/10 |
DOCETAXEL EBEWE |
20mg/2ml |
1 |
Injectable solution |
Infusion |
Khalil Fattal & Fils S.A.L. |
Fareva Unterach GmbH |
Austria |
5,313,553 L.L |
23.08 |
B |
Ebewe Pharma GesmbH.NFG.KG |
Austria |
03/07/20 |
|
L01CD02 |
G |
Docetaxel - 40mg/ml |
3576 |
194595/04 |
DOCETAXEL GP PHARM |
20mg/0.5ml |
1 x 0.5ml + 1.5ml |
Injectable concentrated solution+diluent |
Infusion |
Mediterranean Pharmaceutical Company |
GP-Pharm, SA |
Argentine |
4,567,721 L.L |
23.08 |
B |
|
|
03/07/20 |
|